drugset
drugset / Trial / NCT07404735

A Clinical Trial to Compare and Evaluate Evaluate the Pharmacokinetics and Safety of CKD-846

NCT07404735 ↗

Phase 1 Not yet recruiting 32 enrolled Chong Kun Dang Pharmaceutical
RandomizedParallel-groupOpen-labelTreatment

Summary

A Clinical trial to compare and evaluate evaluate the pharmacokinetics and safety of CKD-846

Timeline

Start
2026-02-23
Primary completion
2026-05-27
Completion
2026-06-02

Drugs

EvaluationDrugModalityDoseRoute
Subject CKD-846 Unknown — —
Subject D091 Unknown — —

Indications

benign prostatic hyperplasia